What is the Sun Pharma Advanced Research Company Ltd share price today?

The share price of NSE:SPARC-EQ on 07 Sep 2026 (as of 11:00:17 IST) is ₹205.75.

What is the NSE:SPARC-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:SPARC-EQ 52 week high low range shows a high of ₹289.00 and a low of ₹108.00.

What is the Sun Pharma Advanced Research Company Ltd market cap?

As on 07 Sep 2026, Sun Pharma Advanced Research Company Ltd market cap is ₹6474.21 Cr.

What is the shareholding pattern of Sun Pharma Advanced Research Company Ltd Stock?

The shareholding pattern of Sun Pharma Advanced Research Company Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 65.67% Foreign Institutional Investors (FII): 3.90% Domestic Institutional Investors (DII): 0% Mutual Funds: 0.08% Retail & Others: 30.35% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Sun Pharma Advanced Research Company Ltd?

The Price-to-Earnings (PE) ratio of Sun Pharma Advanced Research Company Ltd is 4.09, and the Price-to-Book (PB) ratio is 2.78, as on 07 Sep 2026.

Sun Pharma Advanced Research Company Share Price

196.10+2.18 (+1.12%)

+36.86% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+1.12%

1 Week

+5.66%

1 Month

-0.31%

3 Month

-16.52%

6 Month

+49.18%

YTD

+45.85%

1 Year

+36.86%

5 Year

-31.06%

10 Year

-43.11%

Max

+130.16%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

193.00

183.08

182.00

113.91

108.00

High

198.33

198.60

209.90

289.00

About

Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. The Read more

Business Support

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

PFOCUSNSE

SAGILITYNSE

HORIZONINDNSE

SYNGENENSE

INDGNNSE

IGILNSE

NESCONSE

SMARTWORKSNSE

SPARCNSE

LEAPINDNSE

LTP

1W Low

1W High

Market cap (₹)

352.65+32.2 (10.05%)

317.25

355

26,833Cr

45.95+0.93 (2.07%)

44.45

46.70

21,361Cr

52.74-0.17 (-0.32%)

51.89

54.50

15,623Cr

385.15+5.05 (1.33%)

360.40

387.05

14,906Cr

595.95+22.75 (3.97%)

568.80

611.70

14,398Cr

323.2+8.8 (2.80%)

311.80

337.90

14,302Cr

1081.9+6.3 (0.59%)

1073

1124.10

7,745Cr

537.8+17.6 (3.38%)

511.70

560.95

6,304Cr

196.1+10.51 (5.66%)

183.08

198.60

6,297Cr

145.9+11.19 (8.31%)

133.78

147.50

6,181Cr

Sun Pharma Advanced Research Company Share Price

196.10+2.18 (+1.12%)

+36.86% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Sun Pharma Advanced Research Company Share Price

196.10+2.18 (+1.12%)

+36.86% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years99%

Last year2518%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year553%

Stock Price CAGR

10 years-6%

5 years-7%

3 years-6%

1 year35%

Return on Equity

10 years28%

5 years28%

3 years52%

Last year277%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	99%	2518%
-	-	-	553%
-6%	-7%	-6%	35%
28%	28%	52%	277%

Peer Comparison

Symbol

PFOCUS

SAGILITY

HORIZONIND

SYNGENE

INDGN

IGIL

NESCO

SMARTWORKS

SPARC

LEAPIND

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
352.65	₹26833 Cr	232.16	-0.53	10.52	₹219 Cr
45.95	₹21361 Cr	21.51	0.46	3.18	₹925 Cr
52.74	₹15623 Cr	—	-0.04	0.24	-₹198 Cr
385.15	₹14906 Cr	67.45	-0.22	16.72	₹317 Cr
595.95	₹14398 Cr	35.91	4.83	22.82	₹401 Cr
323.2	₹14302 Cr	23.46	3.84	15.26	₹711 Cr
1,081.9	₹7745 Cr	18.59	14.19	66.2	₹413 Cr
537.8	₹6304 Cr	226.15	1.15	81.21	₹11 Cr
196.1	₹6297 Cr	3.97	-0.64	49.12	₹1553 Cr
145.9	₹6181 Cr	99.14	2.05	6.05	₹62 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
₹40 Cr	₹1853 Cr	₹8 Cr	₹8 Cr	₹10 Cr	₹27 Cr	₹15 Cr	₹13 Cr	₹17 Cr	₹17 Cr	₹14 Cr	₹21 Cr	₹24 Cr	₹48 Cr
₹24 Cr	₹2 Cr	₹0	₹1 L	₹9 Cr	₹0	₹19 L	₹4 L	₹2 Cr	₹4 Cr	₹6 Cr	₹8 Cr	₹10 Cr	₹11 Cr
₹64 Cr	₹1855 Cr	₹8 Cr	₹8 Cr	₹19 Cr	₹27 Cr	₹15 Cr	₹13 Cr	₹18 Cr	₹21 Cr	₹20 Cr	₹30 Cr	₹34 Cr	₹58 Cr
₹76 Cr	₹82 Cr	₹68 Cr	₹76 Cr	₹64 Cr	₹83 Cr	₹92 Cr	₹119 Cr	₹113 Cr	₹125 Cr	₹120 Cr	₹116 Cr	₹129 Cr	₹140 Cr
-₹10 Cr	₹1775 Cr	-₹57 Cr	-₹66 Cr	-₹43 Cr	-₹53 Cr	-₹74 Cr	-₹103 Cr	-₹92 Cr	-₹101 Cr	-₹96 Cr	-₹83 Cr	-₹92 Cr	-₹79 Cr
₹8 Cr	₹12 Cr	₹9 Cr	₹8 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹1 Cr	₹56 L	₹91 L	₹26 L	₹26 L	₹26 L	₹21 L
-₹21 Cr	₹1761 Cr	-₹80 Cr	-₹76 Cr	-₹52 Cr	-₹61 Cr	-₹79 Cr	-₹107 Cr	-₹96 Cr	-₹105 Cr	-₹100 Cr	-₹86 Cr	-₹95 Cr	-₹82 Cr
-₹21 Cr	₹1761 Cr	-₹80 Cr	-₹76 Cr	-₹52 Cr	-₹60 Cr	-₹80 Cr	-₹107 Cr	-₹96 Cr	-₹106 Cr	-₹100 Cr	-₹86 Cr	-₹95 Cr	-₹82 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023
—	—	—	—
₹32 Cr	₹32 Cr	₹32 Cr	₹32 Cr
₹1306 Cr	-₹249 Cr	₹93 Cr	₹480 Cr
₹1306 Cr	-₹249 Cr	₹93 Cr	₹480 Cr
₹1339 Cr	-₹217 Cr	₹126 Cr	₹513 Cr
₹0	₹100 Cr	₹0	₹0
-₹2 Cr	-₹2 Cr	-₹1 Cr	₹0
₹66 Cr	₹71 Cr	₹118 Cr	₹130 Cr
₹12 Cr	₹8 Cr	₹6 Cr	₹8 Cr
₹76 Cr	₹176 Cr	₹123 Cr	₹138 Cr
—	—	—	—
₹97 Cr	₹114 Cr	₹142 Cr	₹148 Cr
₹88 Cr	₹94 Cr	₹62 Cr	₹24 Cr
₹556 Cr	₹158 Cr	₹47 Cr	₹5 L
₹13 Cr	₹8 Cr	₹14 Cr	₹6 Cr
₹754 Cr	₹374 Cr	₹265 Cr	₹179 Cr
₹2169 Cr	₹333 Cr	₹514 Cr	₹830 Cr
₹85 Cr	₹85 Cr	₹84 Cr	₹84 Cr
₹556 Cr	₹258 Cr	₹47 Cr	₹5 L
—	—	—	—
₹144 Cr	₹158 Cr	₹157 Cr	₹146 Cr
₹59 Cr	₹59 Cr	₹50 Cr	₹40 Cr
₹85 Cr	₹99 Cr	₹108 Cr	₹106 Cr
₹50 L	₹56 L	₹1 Cr	₹2 Cr
₹121 Cr	₹128 Cr	₹68 Cr	₹65 Cr
₹29 Cr	₹26 Cr	₹25 Cr	₹178 Cr
₹306 Cr	₹307 Cr	₹244 Cr	₹375 Cr
—	—	—	—
₹0	₹0	₹2 Cr	₹291 Cr
₹8 Cr	₹16 Cr	₹16 Cr	₹33 Cr
₹1 Cr	₹2 Cr	₹155 Cr	₹112 Cr
₹1843 Cr	₹4 Cr	₹42 Cr	₹4 Cr
₹10 Cr	₹4 Cr	₹54 Cr	₹16 Cr
₹1862 Cr	₹26 Cr	₹269 Cr	₹455 Cr
₹1108 Cr	-₹348 Cr	₹4 Cr	₹276 Cr
₹2169 Cr	₹333 Cr	₹514 Cr	₹830 Cr
₹41	-₹7	₹4	₹16
₹41	-₹7	₹4	₹16

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023
₹1553 Cr	-₹343 Cr	-₹387 Cr	-₹223 Cr
₹41 Cr	₹21 Cr	-₹11 Cr	₹7 Cr
-₹1865 Cr	-₹47 Cr	-₹27 Cr	₹141 Cr
-₹270 Cr	-₹369 Cr	-₹425 Cr	-₹74 Cr
-₹239 Cr	-₹360 Cr	-₹429 Cr	-₹69 Cr
-₹23 Cr	₹158 Cr	₹392 Cr	-₹548 Cr
₹261 Cr	₹199 Cr	₹42 Cr	₹617 Cr
-₹89 L	-₹3 Cr	₹5 Cr	-₹64 L
₹2 Cr	₹5 Cr	₹58 L	₹1 Cr
₹8 L	₹1 L	₹20,000	₹0
₹1 Cr	₹2 Cr	₹5 Cr	₹58 L

Fundamental Ratios

Consolidated

Standalone

No results found

Sun Pharma Advanced Research Company Share Price

196.10+2.18 (+1.12%)

+36.86% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Sun Pharma Advanced Research Company Share Price

196.10+2.18 (+1.12%)

+36.86% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 1

Bearish signals: 4 out of 9 oscillators

RSI

46.57Neutral

STOCH %K

52.91Neutral

MACD Level(12,26)

-3.72Sell

Ultimate Oscillator

40.31Sell

Aroon Oscillator

-94.00Sell

BOP

0.41Buy

CCI

-30.44Neutral

Williams %R

-47.09Neutral

Momentum

-3.23Sell

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 4

Bearish signals: 5 out of 9 moving averages

EMA 9

194.73Buy

SMA 9

194.84Buy

EMA 21

197.73Sell

SMA 21

197.17Sell

EMA 50

203.34Sell

SMA 50

207.93Sell

EMA 200

182.63Buy

SMA 200

170.73Buy

WMA 20

196.33Sell

Pivot

Classic

Resistance 5

219.81

Resistance 4

213.60

Resistance 3

207.39

Resistance 2

201.18

Resistance 1

197.55

Pivot

194.97

Support 1

191.34

Support 2

188.76

Support 3

182.55

Support 4

176.34

Support 5

170.13

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

193.00

183.08

182.00

113.91

108.00

81.00

35.17

High

198.33

198.60

209.90

289.00

472.80

532.00

593.96

Returns

+2.18

+10.51

-0.61

-38.82

+64.65

+61.65

+52.82

-35.25

-88.35

-148.60

+110.90

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Sun Pharma Advanced Research Company Share Price

196.10+2.18 (+1.12%)

+36.86% past 1 Year

Shareholding summary

Promoters

65.67%

FII

3.9%

DII

0%

MF

0.08%

Others

30.35%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
65.67%	65.67%	65.67%	65.67%	65.67%	65.67%
3.90%	2.04%	2.04%	1.76%	1.48%	1.45%
0.00%	0.02%	0.02%	0.02%	0.02%	0.11%
0.08%	0.85%	0.76%	1.01%	0.94%	1.01%
30.35%	31.42%	31.51%	31.54%	31.89%	31.76%

Bulk & block deals

Name

Hrti Private Limited

Junomoneta Finsol Private Limited

Nk Securities Research Private Limited

Microcurves Trading Private Limited

Qe Securities Llp

Junomoneta Finsol Private Limited

Hrti Private Limited

Nk Securities Research Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
26 May 2026	Purchase	47.78 Cr	₹240.53	19.86 L	Bulk	0.612128	NSE
26 May 2026	Sell	45.67 Cr	₹240.86	18.96 L	Bulk	0.584224	NSE
25 May 2026	Purchase	57.45 Cr	₹226.90	25.32 L	Bulk	0.780262	NSE
25 May 2026	Purchase	55.07 Cr	₹227.49	24.21 L	Bulk	0.745965	NSE
25 May 2026	Purchase	50.43 Cr	₹227.43	22.17 L	Bulk	0.683243	NSE
25 May 2026	Purchase	48.60 Cr	₹228.31	21.29 L	Bulk	0.656001	NSE
25 May 2026	Purchase	41.09 Cr	₹227.12	18.09 L	Bulk	0.557461	NSE
25 May 2026	Sell	54.54 Cr	₹227.61	23.96 L	Bulk	0.738402	NSE
25 May 2026	Sell	53.51 Cr	₹226.35	23.64 L	Bulk	0.72845	NSE
25 May 2026	Sell	50.45 Cr	₹227.54	22.17 L	Bulk	0.683243	NSE

Insider trading & SAST

Client name

Shanghvi Finance Pvt Ltd & Pacs

Shanghvi Finance Private Limited

Jayant Shantilal Sanghvi

Sudhir Vrundavandas Valia

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
10 Jun 2026	Promoter	Acquisition	—	65.67	0	—	3.85 Cr	19 May 2026	Pref. Allotment	25,16,25,095	SAST	29(2)	—
21 May 2026	Promoter Group	Acquisition	11.866699	100	150 Cr	₹38.95	3.85 Cr	19 May 2026	Preferential Offer	3,85,10,000	Insider Trading	—	Warrants
24 Dec 2024	Promoter	Pledge	—	—	0	—	4.87 L	10 Mar 2015	Creation	11,62,066	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	0	—	0	—	1.45 L	20 Jan 2016	Creation	11,62,066	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	0	—	0	—	3.55 L	19 Jan 2016	Creation	10,16,751	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	0	—	0	—	5 L	14 Jan 2016	Release	6,62,066	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	1.45 L	20 Jan 2016	Creation	11,62,066	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	3.55 L	19 Jan 2016	Creation	10,16,751	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	5 L	14 Jan 2016	Release	6,62,066	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	18 L	30 May 2017	Creation	18,00,000	SAST	Reg31	—